Weight Loss News and Research

Latest Weight Loss News and Research

FDA approves Janssen Biotech's SIMPONI ARIATM for infusion for active rheumatoid arthritis

Janssen Biotech, Inc. announced today the U.S. Food and Drug Administration approval of SIMPONI ARIATM (golimumab) for infusion for the treatment of adults with moderately to severely active rheumatoid arthritis in combination with methotrexate.

19 Jul 2013

Pre-diabetic patients who have substantial weight loss reduce their risk of type II diabetes

People with pre-diabetes who lose roughly 10 percent of their body weight within six months of diagnosis dramatically reduce their risk of developing type 2 diabetes over the next three years, according to results of research led by Johns Hopkins scientists.

17 Jul 2013

Coffee and appetite: an interview with Matt Schubert and Associate Professor Ben Desbrow, Griffith University

We wanted to do something a bit different than the “typical” work on caffeine and exercise, and I have considerable interest in appetite regulation, so we built up from there.

15 Jul 2013

Research reveals link between elevated BMI and increased risk of gallstone in women

New research reveals a causal association between elevated body mass index (BMI) and increased risk of gallstone disease. Results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show women are at greater risk of developing gallstones.

12 Jul 2013

FDA issues warning on blood pressure drug, olmesartan medoxomil

Food and Drug Administration (FDA) regulators have issued a warning on the blood pressure drug known generically as olmesartan medoxomil. The drug can cause intestinal problems known as spruelike enteropathy, which has side effects including severe, chronic diarrhea and substantial weight loss, sometimes requiring hospitalization.

11 Jul 2013

Weight loss interventions deliver via conference calls by primary care provider staff are effective

Weight loss interventions delivered via conference calls by primary care provider staff are effective. An intensive lifestyle intervention, proven to help people lose weight to prevent diabetes, also works in primary care when delivered over the telephone to obese patients with metabolic syndrome. Group telephone sessions appear to be particularly effective for greater weight loss, according to a new study by Drs. Paula Trief and Ruth Weinstock from SUNY Upstate Medical University in Syracuse, New York, and colleagues.

10 Jul 2013

HHS awards contract to British company to run Obamacare exchanges; challenges for health law implementation persist

The New York Times: British Company Is Awarded Contract To Administer Health Rollout Racing to meet an October deadline, Obama administration officials said Thursday that they had awarded a contract worth as much as $1.2 billion to a British company to help them sift applications for health insurance and tax credits under the new health care law.

9 Jul 2013

Spanish doctors perform more than 1,500 POSE weight loss procedures

Spanish doctors are leading the way by performing more than 1,500 procedures of the scar-free, non invasive, weight loss method of Primary Obesity Surgery, Endolumenal, known as POSE. Over thirty Spanish doctors have now performed more cases in Spain (where 1 in 6 people are obese) than in any other part of the world.

8 Jul 2013

First Edition: July 8, 2013

Today's early morning highlights from the major news organizations, including news about a new ad campaign against the health law, more reaction to the administration's delay of the employer mandate provision and states efforts to restrict abortions.

8 Jul 2013

First Edition: July 2, 2013

Today's headlines include various reports about changes afoot in the insurance marketplace.

2 Jul 2013

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Bayer HealthCare and Onyx Pharmaceuticals today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration and an application for marketing authorization to the European Medicines Agency for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.

1 Jul 2013

Study: Watching avatar model weight-loss behavior in virtual community may help reduce weight

An estimated two-thirds of all Americans are overweight or obese and many find it difficult to lose weight and keep it off. They've tried fad diets, exercise programs, diet pills and other methods but the battle continues. Now, a new study suggests that watching an avatar model weight-loss behavior in a virtual community might help some women shed pounds in the real world.

1 Jul 2013

Study: Children with Crohn's disease have enterovirus in their intestines

A new study reveals that all children with Crohn's disease that were examined had a commonly occurring virus - an enterovirus - in their intestines. This link has previously not been shown for this chronic inflammatory intestinal disorder. The findings are being published today in the latest issue of the international journal Clinical and Translational Gastroenterology.

28 Jun 2013

FDA approves Novartis' Exelon Patch for treatment of severe Alzheimer's disease

The US Food and Drug Administration has expanded the approved indication for Exelon Patch (rivastigmine transdermal system) to include the treatment of people with severe Alzheimer's disease with Exelon Patch 13.3mg/24h.

28 Jun 2013

Eisai submits BELVIQ NDS with Health Canada

Arena Pharmaceuticals, Inc. announced today that Eisai Limited (based in Mississauga, Ontario), a subsidiary of Eisai Inc., has submitted a New Drug Submission for BELVIQ (lorcaserin HCl) with Health Canada.

26 Jun 2013

Parents’ concern over adolescents’ weight can promote unhealthy habits

Overweight or obese adolescents who were spoken to about their weight by their mothers and fathers were more likely to engage in binge eating and use unhealthy weight-control behaviors than teens whose parents spoke with them in terms of eating healthier, according to a study published in JAMA Pediatrics.

25 Jun 2013

Study finds that triple therapy corrects two core defects in type 2 diabetes

Patients with type 2 diabetes fare significantly better if they are started on three medications at the time of diagnosis than if they are prescribed a single drug and have other therapies added later, a San Antonio researcher said June 22 at the 73rd Scientific Sessions of the American Diabetes Association in Chicago.

25 Jun 2013

Weight loss does not reduce heart disease risks among Type 2 diabetes patients: Study

A landmark study investigating the long-term effects of weight loss on the risks of cardiovascular disease among patients with Type 2 diabetes has now concluded, with significant results to be published today in the New England Journal of Medicine.

25 Jun 2013

Patients with type2 diabetes, renal impairment have less hypoglycemia with JANUVIA compared to sulfonylurea

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc pooled analysis showing patients with type 2 diabetes and mild renal impairment treated with JANUVIA- (sitagliptin) 100 mg once-daily achieved similar blood sugar reductions as those treated with the sulfonylureas glipizide or glimepiride, with significantly fewer events of hypoglycemia (low blood sugar), and with weight loss instead of weight gain.

24 Jun 2013

Research shows athletes who switch focus to other objectives are most successful at achieving main career goals

Research suggests that it is Andy Murray's ability to manage his goals, as well as his skill, determination and motivation that makes him such a successful athlete. Murray dropped out of the French Open after a back injury this year, missing out on his goal of playing in four grand slam finals in a row.

24 Jun 2013

Weight Loss News and Research

Latest Weight Loss News and Research

FDA approves Janssen Biotech's SIMPONI ARIATM for infusion for active rheumatoid arthritis

Pre-diabetic patients who have substantial weight loss reduce their risk of type II diabetes

Coffee and appetite: an interview with Matt Schubert and Associate Professor Ben Desbrow, Griffith University

Research reveals link between elevated BMI and increased risk of gallstone in women

FDA issues warning on blood pressure drug, olmesartan medoxomil

Weight loss interventions deliver via conference calls by primary care provider staff are effective

HHS awards contract to British company to run Obamacare exchanges; challenges for health law implementation persist

Spanish doctors perform more than 1,500 POSE weight loss procedures

First Edition: July 8, 2013

First Edition: July 2, 2013

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Study: Watching avatar model weight-loss behavior in virtual community may help reduce weight

Study: Children with Crohn's disease have enterovirus in their intestines

FDA approves Novartis' Exelon Patch for treatment of severe Alzheimer's disease

Eisai submits BELVIQ NDS with Health Canada

Parents’ concern over adolescents’ weight can promote unhealthy habits

Study finds that triple therapy corrects two core defects in type 2 diabetes

Weight loss does not reduce heart disease risks among Type 2 diabetes patients: Study

Patients with type2 diabetes, renal impairment have less hypoglycemia with JANUVIA compared to sulfonylurea

Research shows athletes who switch focus to other objectives are most successful at achieving main career goals

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Weight Loss News and Research

Latest Weight Loss News and Research

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Newsletters you may be interested in